Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

NRSN – neurosense therapeutics ltd. - ordinary shares (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRSN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/6
09:20 am
nrsn
Form 6-K NeuroSense Therapeutics For: Apr 06
Medium Report
Form 6-K NeuroSense Therapeutics For: Apr 06
Report
4/3
09:27 am
nrsn
Form 6-K NeuroSense Therapeutics For: Apr 03
Medium Report
Form 6-K NeuroSense Therapeutics For: Apr 03
Report
4/1
04:26 pm
nrsn
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Eisenberg Or
Medium Report
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Eisenberg Or
Report
4/1
04:25 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Eisenberg Or
Medium Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Eisenberg Or
Report
3/31
04:17 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Mandil-Levin Revital
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Mandil-Levin Revital
Report
3/31
09:30 am
nrsn
Form 20-F NeuroSense Therapeutics For: Dec 31
Medium Report
Form 20-F NeuroSense Therapeutics For: Dec 31
Report
3/31
09:30 am
nrsn
Form 6-K NeuroSense Therapeutics For: Mar 31
Medium Report
Form 6-K NeuroSense Therapeutics For: Mar 31
Report
3/30
05:35 pm
nrsn
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Russek-Blum Niva
Medium Report
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Russek-Blum Niva
Report
3/30
05:35 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Russek-Blum Niva
Medium Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Russek-Blum Niva
Report
3/30
08:52 am
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Ben-Noon Alon
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Ben-Noon Alon
Report
3/30
08:49 am
nrsn
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Binder Hagit
Low Report
Form 4 NeuroSense Therapeutics For: Mar 26 Filed by: Binder Hagit
Report
3/24
10:11 am
nrsn
Form 6-K NeuroSense Therapeutics For: Mar 24
Low Report
Form 6-K NeuroSense Therapeutics For: Mar 24
Report
3/18
03:56 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Pellizzari Christine A
Medium Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Pellizzari Christine A
Report
3/18
03:36 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Claiborne Cary J
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Claiborne Cary J
Report
3/18
03:36 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Tracik Ferenc
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Tracik Ferenc
Report
3/18
03:36 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Leuchtenberger Mark
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Leuchtenberger Mark
Report
3/18
03:36 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Golan Roy
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Golan Roy
Report
3/18
03:35 pm
nrsn
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Binder Hagit
Low Report
Form 3 NeuroSense Therapeutics For: Mar 18 Filed by: Binder Hagit
Report
3/16
12:28 pm
nrsn
Form 6-K NeuroSense Therapeutics For: Mar 16
Low Report
Form 6-K NeuroSense Therapeutics For: Mar 16
Report
3/11
08:00 am
nrsn
Form 6-K NeuroSense Therapeutics For: Mar 11
Low Report
Form 6-K NeuroSense Therapeutics For: Mar 11
Report
2/18
09:21 am
nrsn
Form 6-K NeuroSense Therapeutics For: Feb 18
High Report
Form 6-K NeuroSense Therapeutics For: Feb 18
Report
2/13
04:35 pm
nrsn
Form 6-K NeuroSense Therapeutics For: Feb 13
Medium Report
Form 6-K NeuroSense Therapeutics For: Feb 13
Report
2/9
09:30 am
nrsn
Form 6-K NeuroSense Therapeutics For: Feb 09
High Report
Form 6-K NeuroSense Therapeutics For: Feb 09
Report
1/29
05:28 pm
nrsn
Form F-3 NeuroSense Therapeutics
Low Report
Form F-3 NeuroSense Therapeutics
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0